- XRP ETF decision deadline missed; continuation of regulatory reviews.
- No official rejection or further leadership commentary available.
- Institutional interest in XRP remains strong; monitoring on-chain metrics.
Ripple’s XRP spot ETF faces another missed deadline without confirmation of approval from the U.S. SEC, extending the review period to November 14, 2025.
The delay sustains regulatory uncertainty, impacting institutional interest in XRP, while maintaining market optimism for future institutional capital inflows.
Lede
Ripple’s XRP spot ETF faced another missed deadline in the U.S., adding to the regulatory review process. As of October 27, 2025, no formal rejection has been communicated.
Involved parties include Ripple Labs, the SEC, and potentially Evernorth Holdings, who seek to influence the ETF agenda with a Nasdaq listing.
Nut Graph
The protracted review has caused uncertainty but hasn’t deterred institutional interest. XRP remains a focal point for investors eyeing regulatory outcomes. The financial sector watches closely, considering past trends with BTC and ETH. Successful approval could reshape XRP’s market trajectory.
Institutional Interest
Despite the missed deadline, institutional interest in XRP remains strong, indicating that the foundations are being laid for future inflows once clarity is achieved.
Lack of Statements
The lack of new statements from Ripple leadership or the SEC continues to leave the industry guessing. David Schwartz, CTO of Ripple Labs, Inc., stated,
The regulatory landscape continues to evolve, and we are optimistic that the existing frameworks will eventually accommodate our innovative solutions.
Future Decisions
Future decisions could impact financial, regulatory, and technological areas, aligning with prior ETF precedents tied to price volatility post-approval.
